Turning Point Therapeutics Inc - ESG Rating & Company Profile powered by AI
The analysis of Turning Point Therapeutics Inc is prepared by All Street Sevva using cutting edge Cognitive Robots. Browse to the end of this webpage for potential risks for Turning Point Therapeutics Inc based on sector, location and marketcap. This Disclosure score covers 17 UN SDGs including: 'Zero Hunger', 'Industry, Innovation & Infrastructure' and 'Life below Water'.
Turning Point Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 1.1, social score of 3.0 and governance score of 5.0.
3.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1733 | Timber Pharmaceuticals Inc | 3.2 | Medium |
| 1733 | Zhejiang Jiuzhou Pharmaceutical Co Ltd | 3.2 | Medium |
| 1760 | Turning Point Therapeutics Inc | 3.1 | Medium |
| 1760 | Anygen Co Ltd | 3.1 | Medium |
| 1760 | AptaBio Therapeutics Inc | 3.1 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Turning Point Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Turning Point Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Turning Point Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Turning Point Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Turning Point Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Turning Point Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Turning Point Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Turning Point Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Turning Point Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Turning Point Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Turning Point Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Turning Point Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Turning Point Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Turning Point Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Turning Point Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Turning Point Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Turning Point Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Turning Point Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+, or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0022, a MET/CSF1R/SRC inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in Phase 1/2 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, a preclinical ALK inhibitor for advanced non-small-cell lung cancer. The company was founded in 2013 and is headquartered in San Diego, California.